SEC 13F Intelligence

Notis-Mcconarty Edward / VRTX

Notis-Mcconarty Edward’s Vertex Pharmaceuticals Inc Position

Does Notis-Mcconarty Edward own Vertex Pharmaceuticals Inc (VRTX)? Yes — 7.9K shares worth $4M (+1.75% of its 13F portfolio) as of Q1 2026, up from 7.9K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
7.9K
% of Portfolio
+1.75%
Quarters Held
9
currently held

Position History VRTX

Reported value by quarter
Q1 ’24: $553,864Q1 ’24Q2 ’24: $2MQ3 ’24: $2MQ3 ’24Q4 ’24: $3MQ1 ’25: $4MQ1 ’25Q2 ’25: $3MQ3 ’25: $3MQ3 ’25Q4 ’25: $4MQ1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.9K$4M+1.75%
Q4 20257.9K$4M+1.65%
Q3 20257.8K$3M+1.42%
Q2 20257.4K$3M+1.60%
Q1 20257.3K$4M+1.81%
Q4 20246.5K$3M+1.27%
Q3 20245.3K$2M+1.11%
Q2 20243.8K$2M+0.70%
Q1 20241.3K$553,864+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Notis-Mcconarty Edward’s full portfolio or all institutional holders of VRTX.